Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents.
Two subclones of L1210 murine leukemia (L1210-46.1 and L1210-56.3) were isolated in the absence of selective agents. Subclone 56.3 appeared to be more sensitive than was subclone 46.1 to treatment with dexamethasone, 1-beta-D-arabinofuranosyl cytosine, vincristine, and X-irradiation. No differences between the parent cells and the two subclones could be observed in population-doubling time, cloning efficiency, number of chromosomes, and tumorigenic potential in DBA/2 mice. The subclones did not differ in the per cell number of glucocorticoid receptor sites. Animal experiments revealed an increase in life span of 65% in mice inoculated with cells from subclone 46.1 and of 130% of mice with subclone 56.3 after treatment with 1-beta-D-arabinofuranosylcytosine. The present results indicate that the L1210 wild-type murine leukemia cells contained stable subpopulations with a different but collateral sensitivity to various cytotoxic treatments. It is postulated that differences in drug sensitivity between cells are partly determined by cellular properties which are independent of the mechanism of action of any specific treatment.
D000818:Animals; D002469:Cell Separation; D002470:Cell Survival / Q000187:drug effects; D002999:Clone Cells / Q000473:pathology; D003561:Cytarabine / Q000494:pharmacology; D003603:Cytotoxins / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D007939:Leukemia L1210 / Q000473:pathology*; D051379:Mice; D014750:Vincristine / Q000494:pharmacology
D003603:Cytotoxins; D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone